(redirected from 3,4-methylenedioxymethamphetamine)
Also found in: Dictionary, Medical, Acronyms.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for methylenedioxymethamphetamine

a stimulant drug that is chemically related to mescaline and amphetamine and is used illicitly for its euphoric and hallucinogenic effects

References in periodicals archive ?
Studies of {+/-} 3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: Relationship to neuroprotection and neurotoxicity profile.
Incidence of recreational use of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on an undergraduate campus.
5 mg/g 3,4-methylenedioxymethamphetamine (MDMA, also nown as Ecstasy) at wee 1, one oral dose of 1.
A patent was issued to the Merck chemical company in 1914 to produce 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') as an appetite suppressant (Beck and Rosenbaum, 1994).
Cross-reactivity with methamphetamine, amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) (ecstasy) is considered an advantage because only one screen adequately covers the three most commonly abused drugs, while cross-reactivity with phenylpropanolamine, ephedrines and other common cold medication ingredients is a disadvantage, due to the need for expensive and time-consuming confirmatory procedures to rule out these drugs.
Mood and cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): Week-end "high" followed by mid-week low.
The following compounds were purchased from Lipomed GmbH: morphine, amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA), codeine, 6-acetylmorphine, methadone, cocaine, benzoylecgonine, 3,4-methylenedioxy-N-ethylamphetamine (MDEA), nordiazepam, 7-aminonitrazepam, 7-aminoclonazepam, 7-aminoflunitrazepam, chlordiazepoxide, lorazepam, zopiclone, buprenorphine, 7-aminoflunitrazepam-[d.
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") is a ring-substituted phenethylamine with a chemical structure related both to mescaline and methamphetamine.
Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.
The drugs most commonly combined with GHB were 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") (n = 7, 54%) and crystal methamphetamine (n = 7, 54%).
3,4-Methylenedioxymethamphetamine (MDMA), [1] commonly known as Ecstasy, is an illicit drug ingested for its stimulatory and hallucinogenic effects (1,2).
A number of investigators have reported clinical study results for opiates (4, 12, 13), cocaine (8, 9, 14-17), MAMP (18), and 3,4-methylenedioxymethamphetamine (MDMA) (19).
Amphetamine (AM) [4], methamphetamine (MA), and the amphetamine-derived designer drugs 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (ecstasy, MDMA), and 3,4-methylenedioxyethylamphetamine (MDEA) are widely abused recreational drugs.
Methylenedioxy derivatives of amphetamines, 3,4-methylenedioxyamphetamine (MDA) (3) 3,4-methylenedioxyethylamphetamine (MDEA), and 3,4-methylenedioxymethamphetamine (MDMA), constitute a major class of central nervous system stimulants producing well described cardiovascular and behavioral effects (1,2).
Full browser ?